Ticagrelor or prasugrel in patients with acute coronary syndrome and prior myocardial infarction

Back

ESC Professional Premium Access

Ticagrelor or prasugrel in patients with acute coronary syndrome and prior myocardial infarction

Session: Platelets and more

Topic: Pharmacotherapy

Speaker: Doctor M. Scalamogna (Napoly, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Maria Scalamogna

Federico II University Hospital, Napoly (Italy)

0 follower

8 more presentations in this session

Clopidogrel monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome post-drug-eluting stent implantation: a systematic review and direct/indirect treatment comparison

Speaker: Professor D. Sibbing (Munich, DE)

Access

Abstract

Slides

Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Access

Abstract

Slides

Antithrombotic and proton pump inhibitor co-therapy in patients with atrial fibrillation and stable coronary disease: a post hoc analysis of the AFIRE trial

Speaker: Doctor H. Wada (Izunokuni, JP)

Access

Abstract

Slides

Clinical significance of time-varying on-treatment platelet reactivity after percutaneous coronary intervention

Speaker: Professor Y. Jeong (Gwangmyeong, KR)

Access

Abstract

Slides

Beta-blockers in acute coronary syndrome: does rhythm matter?

Speaker: Doctor C. Carvalho (Vila Real, PT)

Access

Abstract

Slides

Access the full session

Platelets and more

Speakers: Doctor M. Scalamogna, Professor D. Sibbing, Professor U. Zeymer, Doctor H. Wada, Professor Y. Jeong...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources